Assistance Listing 93.AR7
Arthritis, Musculoskeletal and Skin Diseases Research - SBIR/STTR
HEALTH AND HUMAN SERVICES, DEPARTMENT OF · National Institutes of Health
Assistance Listing 93.AR7, “Arthritis, Musculoskeletal and Skin Diseases Research - SBIR/STTR,” is a federal program administered by HEALTH AND HUMAN SERVICES, DEPARTMENT OF. It provides grant assistance. GrantsJunction currently tracks 0 open, 0 forecasted and 0 closed opportunities under this listing. The agency reported $20.1M in obligations for fiscal year 2025.
Program objective
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) mission is to support research into the causes, treatment, and prevention of arthritis and musculoskeletal and skin diseases; training of basic and clinical scientists to carry out this research; and dissemination of information on research progress in these diseases. The Extramural Program promotes and supports basic, translational, and clinical studies of Systemic Rheumatic and Autoimmune Diseases, Skin Biology and Diseases, Bone Biology and Diseases, Muscle Biology and Diseases, and Joint Biology and Diseases and Orthopedics. NIAMS Systemic Rheumatic and Autoimmune Diseases programs address basic, translational, and clinical research, including clinical trials and observational and mechanistic studies, focused on immune-mediated arthritis and autoimmune-related acute and chronic disorders in adults and children. NIAMS Skin Biology and Diseases programs support basic, translational, and clinical research in skin, including both common and rare skin diseases. These programs include investigations of the basic molecular, cellular, and developmental biology of skin, as well as studies of skin as an immune, sensory, endocrine, and metabolic organ. NIAMS Bone Biology and Diseases programs support research on the control of bone formation, resorption, and mineralization as well as the effects of signaling molecules on bone cells. They sup-port clinical studies of interventions to prevent fractures associated with osteoporosis and research into less common bone diseases. NIAMS Muscle Biology and Diseases programs encourage research on muscle developmental biology, growth, maintenance, and hypertrophy; physiology of contraction; structural biology of the contractile apparatus; disease mechanisms; biomarkers and outcome measures; and development and clinical testing of therapies for conditions including the muscular dystrophies. NIAMS Joint Biology, Diseases, and Orthopedics programs support a broad spectrum of research centered on the interplay among the body’s muscles, bones, and connective tissues. They encourage tissue engineering and regenerative medicine research, molecular biology, imaging, and clinical research, and the treatment and prevention of orthopedic conditions.
As published in the SAM.gov Assistance Listing.
Current opportunities under 93.AR7
No open or forecasted opportunities are currently posted under this listing. Programs often post notices on an annual cycle — see recently closed opportunities below for timing.
Eligible applicants (program level)
- For-Profit Organization
Small business - A business of less than 500 employees, independently owned and not dominant in its field. (Detailed criteria are established by the Small Business Administration.)
Program-level eligibility from SAM.gov. Each funding notice sets its own requirements.
Reported obligations by fiscal year
Historical data · not a predictionFrequently asked questions
What is ALN 93.AR7?
93.AR7 is the Assistance Listing Number for “Arthritis, Musculoskeletal and Skin Diseases Research - SBIR/STTR.” Assistance Listing Numbers (formerly CFDA numbers) identify federal assistance programs; individual grant opportunities reference the listing they are funded under.
Who can apply under ALN 93.AR7?
The SAM.gov listing names these applicant types: For-Profit Organization. Each funding notice under the program sets its own eligibility, so check the specific opportunity.
How much funding does 93.AR7 provide?
The agency reported $20,060,171 in obligations for FY2025 in the SAM.gov Assistance Listing. These are program-wide totals reported by the agency, not a prediction of future awards.